Viewing Study NCT03771820


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:19 AM
Study NCT ID: NCT03771820
Status: UNKNOWN
Last Update Posted: 2021-03-17
First Post: 2018-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Sponsor: NanoCarrier Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module